Clinical Trials Arena November 7, 2022
Blockchain has been billed as a transformative technology that could improve drug traceability in clinical trial supply chains, but many industry experts are skeptical.
Blockchain technology, which safely and securely records valuable data, has emerged as a solution for transparently tracking complex supply chains. However, many experts are doubtful that pharma—generally a conservative and tightly regulated industry—will implement or benefit from this technology.
Experts say the pharma industry has a low appetite for investment in blockchain, particularly given the more promising supply chain tracking alternatives, such as radio frequency identification (RFID). Meanwhile, pharma supply chains are already tightly regulated, so the industry cannot benefit from blockchain the way other industries might.
“Blockchain is a...
Today's Sponsors
Today's Sponsor